ASCO conference

• Science & Technology
• Health & Medicine

New immunotherapy drugs hit the headlines - how do they work?

In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers. In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers.

2 June 2014

• Science & Technology

ASCO 2013 – personalised medicine: potential and challenges

7 June 2013

• Science & Technology

ASCO 2013 – clinical trials for older cancer patients

5 June 2013

• Science & Technology

ASCO 2013 - doctors encourage cancer patients to quit smoking

4 June 2013

• Science & Technology
• Health & Medicine

Podcast: Curry chemical on trial, death rates fall, ASCO conference highlights and more

18 June 2012

• Science & Technology

ASCO 2012 – best of the rest

7 June 2012

• Science & Technology

ASCO 2012 – a new treatment for HER2-positive breast cancer?

6 June 2012

• Health & Medicine
• Science & Technology

ASCO 2012: Is immunotherapy finally coming of age?

6 June 2012

• Science & Technology
• Health & Medicine

ASCO 2011 – Jury still out on ovarian cancer screening

30 June 2011

• Science & Technology
• Health & Medicine

Making research count for patients - the multiple myeloma story

27 June 2011

• Science & Technology
• Health & Medicine

Podcast: New drugs, lung cancer surgery and mobile phones

24 June 2011

• Science & Technology

ASCO 2011 – collection of tweets and online coverage

22 June 2011